Evidence map›Paper›PMID 33360195›Full record

ArticleBioorganic & medicinal chemistry2021

Site-specific covalent labeling of His-tag fused proteins with N-acyl-N-alkyl sulfonamide reagent.

Vikram Thimaradka, Jae Hoon Oh, Christina Heroven, A Radu Aricescu, Michisuke Yuzaki, Tomonori Tamura, Itaru Hamachi

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Expediated synthesis ofOrganic & biomolecular chemistry · 2026
    Article
  4. N-Acyl-N-Alkyl Sulfonamide Mediated Bioconjugation ofHis-Tag Fused Proteins.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  5. Peptide Tags for Site-Selective Nonenzymatic Covalent Modification of Proteins.Journal of peptide science : an official publication of the European Peptide Society · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vikram ThimaradkaDepartment of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Katsura, Nishikyo-ku, Kyoto 615-8510, Japan.
Jae Hoon OhERATO (Exploratory Research for Advanced Technology, JST), Sanbancho, Chiyodaku, Tokyo, 102-0075, Japan.
Christina HerovenDivision of Structural Biology, University of Oxford, Oxford OX3 7BN, UK; Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.
A Radu AricescuDivision of Structural Biology, University of Oxford, Oxford OX3 7BN, UK; Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.
Michisuke YuzakiDepartment of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Tomonori TamuraDepartment of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Katsura, Nishikyo-ku, Kyoto 615-8510, Japan. Electronic address: tamura@sbchem.kyoto-u.ac.jp.
Itaru HamachiDepartment of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Katsura, Nishikyo-ku, Kyoto 615-8510, Japan; ERATO (Exploratory Research for Advanced Technology, JST), Sanbancho, Chiyodaku, Tokyo, 102-0075, Japan. Electronic address: ihamachi@sbchem.kyoto-u.ac.jp.

Funding

Medical Research Council MC_EX_MR/L009609/2Medical Research Council MC_UP_1201/15
6 · The paper itself

Abstract

The ability to incorporate a desired functionality into proteins of interest in a site-specific manner can provide powerful tools for investigating biological systems and creating therapeutic conjugates. However, there are not any universal methods that can be applied to all proteins, and it is thus important to explore the chemical strategy for protein modification. In this paper, we developed a new reactive peptide tag/probe pair system for site-specific covalent protein labeling. This method relies on the recognition-driven reaction of a peptide tag and a molecular probe, which comprises the lysine-containing short histidine tag (KH6 or H6K) and a binuclear nickel (II)- nitrilotriacetic acid (Ni

Indexed as

Staining and LabelingHEK293 CellsHistidineHumansIndicators and ReagentsLysineModels, MolecularMolecular ProbesMolecular StructureNickelNitrilotriacetic AcidProteinsSulfonamidesHistidineIndicators and ReagentsLysineMolecular ProbesNickelNitrilotriacetic AcidProteinsSulfonamides

Identifiers

PMID33360195
PMCPMC7610637

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.